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Abstract: OBJECTIVES Traumatic brain injury is the number one cause of death in children and young
adults and has become increasingly prevalent in the elderly. Decompressive craniectomy prevents in-
tracranial hypertension but does not clearly improve physical outcome 6 months after traumatic brain
injury. However, it has not been analyzed if decompressive craniectomy affects traumatic brain injury pa-
tients’ quality of life in the long term. DESIGN Therefore, we conducted a cross-sectional study assessing
health-related quality of life in traumatic brain injury patients with or without decompressive craniectomy
up to 10 years after injury. SETTING Former critical care patients. PATIENTS Chronic traumatic brain
injury patients having not (n = 37) or having received (n = 98) decompressive craniectomy during the
acute treatment. MEASUREMENTS AND MAIN RESULTS The Quality of Life after Brain Injury ques-
tionnaire was used as outcome measure with a total score from zero to 100, representing lowest and best
health-related quality of life, respectively. Health-related quality of life was compared between patients
with or without decompressive craniectomy for the entire cohort, for the traumatic brain injury severity
(mild, moderate, severe) measured by the initial Glasgow Coma Scale, for age and time variables (age at
traumatic brain injury, age at survey, elapsed time since traumatic brain injury) using the Mann-Whitney
U test. Differences were considered significant at a p value of less than 0.05.Decompressive craniectomy
was necessary in all initial traumatic brain injury severity groups. Eight percent more decompressive
craniectomy patients reported good health-related quality of life with a Quality of Life after Brain Injury
total score greater than or equal to 60 compared with the no decompressive craniectomy patients up to
10 years after traumatic brain injury (p = 0.004). Initially, mild classified traumatic brain injury patients
had a median Quality of Life after Brain Injury total score of 83 (decompressive craniectomy) versus 62
(no decompressive craniectomy) (p = 0.028). Health-related quality of life regarding physical status was
better in decompressive craniectomy patients (p = 0.025). Decompressive craniectomy showed a trend
toward better health-related quality of life in the 61-85-year-old reflected by median Quality of Life after
Brain Injury total scores of 62 (no decompressive craniectomy) versus 79 (decompressive craniectomy) (p
= 0.06). CONCLUSIONS Our results suggest that decompressive craniectomy is associated with good
health-related quality of life up to 10 years after traumatic brain injury. Thus, decompressive craniectomy
may have an underestimated therapeutic potential after traumatic brain injury.
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Objectives: Traumatic brain injury is the number one cause of 
death in children and young adults and has become increasingly 
prevalent in the elderly. Decompressive craniectomy prevents in-
tracranial hypertension but does not clearly improve physical out-
come 6 months after traumatic brain injury. However, it has not 
been analyzed if decompressive craniectomy affects traumatic 
brain injury patients’ quality of life in the long term.
Design: Therefore, we conducted a cross-sectional study assess-
ing health-related quality of life in traumatic brain injury patients with 
or without decompressive craniectomy up to 10 years after injury.
Setting: Former critical care patients.
Patients: Chronic traumatic brain injury patients having not (n = 
37) or having received (n = 98) decompressive craniectomy dur-
ing the acute treatment.
Measurements and Main Results: The Quality of Life after Brain In-
jury questionnaire was used as outcome measure with a total score 
from zero to 100, representing lowest and best health-related quality 
of life, respectively. Health-related quality of life was compared be-
tween patients with or without decompressive craniectomy for the 
entire cohort, for the traumatic brain injury severity (mild, moderate, 
severe) measured by the initial Glasgow Coma Scale, for age and 
time variables (age at traumatic brain injury, age at survey, elapsed 
time since traumatic brain injury) using the Mann-Whitney U test. Dif-
ferences were considered significant at a p value of less than 0.05. 
Decompressive craniectomy was necessary in all initial traumatic 
brain injury severity groups. Eight percent more decompressive cra-
niectomy patients reported good health-related quality of life with a 
Quality of Life after Brain Injury total score greater than or equal to 
60 compared with the no decompressive craniectomy patients up to 
10 years after traumatic brain injury (p = 0.004). Initially, mild classi-
fied traumatic brain injury patients had a median Quality of Life after 
Brain Injury total score of 83 (decompressive craniectomy) versus 
62 (no decompressive craniectomy) (p = 0.028). Health-related 
quality of life regarding physical status was better in decompres-
sive craniectomy patients (p = 0.025). Decompressive craniectomy 
showed a trend toward better health-related quality of life in the 
61–85-year-old reflected by median Quality of Life after Brain In-
jury total scores of 62 (no decompressive craniectomy) versus 79 
(decompressive craniectomy) (p = 0.06).
Conclusions: Our results suggest that decompressive craniec-
tomy is associated with good health-related quality of life up to 
10 years after traumatic brain injury. Thus, decompressive crani-
ectomy may have an underestimated therapeutic potential after 
traumatic brain injury. (Crit Care Med 2020; 48:1157–1164)
Key Words: anxiety and depressive disorder; decompressive 
craniectomy; health-related quality of life; long-term outcome 
after traumatic brain injury; psychiatric disorders; traumatic brain 
injury
T
raumatic brain injury (TBI) is the most common cause 
of death and disability among children and young 
adults and has become increasingly prevalent in the 
elderly (1, 2). For many years, experimental and clinical TBI re-
search has primarily focused on the pathophysiology of acute 
and secondary brain injury, but clinical translation of thera-
peutic strategies has largely failed (3–7). In addition, there is 
evolving evidence that TBI is an ongoing chronic disease, since 
about one third of patients deteriorate later than 1 year after 
the head injury (8). Thus, chronic sequelae of TBI has moved 
into the focus of current research.
Decompressive craniectomy (DC) prevents secondary brain 
injury following experimental TBI and improves the outcome DOI: 10.1097/CCM.0000000000004387
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of a subcohort of patients with malignant ischemic stroke (6, 
9). In the case of malignant ischemic stroke, DC was shown to 
improve long-term physical outcome and quality of life (10, 
11). In contrast to stroke, two randomized controlled clinical 
trials evaluating physical outcome after TBI measured by the 
Extended Glasgow Outcome Scale (GOSE), the Randomised 
Evaluation of Surgery with Craniectomy for Uncontrollable 
Elevation of Intracranial Pressure (RESCUEicp) and 
Decompressive Craniectomy (DECRA) trials, failed to clearly 
demonstrate a beneficial effect of secondary DC in TBI patients 
suffering from refractory intracranial hypertension at 6 months 
after the brain injury (12, 13). However, the RESCUEicp anal-
ysis on functional outcome at 12 months showed a tendency 
for functional improvement indicated by higher GOSE scores. 
Thus, to date the effect of DC in patients suffering from TBI 
remains controversial. In contrast to the evaluation of DC 
after malignant ischemic stroke, evidence is still missing as to 
whether DC can improve long-term outcome after TBI and 
whether this improvement not only includes physical perfor-
mance, but also other, more multidimensional outcome vari-
ables, such as health-related quality of life (HRQoL) (14–16). 
Therefore, the aim of the current study is to investigate HRQoL 




Four hundred thirty-nine consecutive TBI patients who were 
admitted to the Schoen Rehabilitation Center, Bad Aibling, 
Germany, between 2005 and 2015 were invited in writing to 
participate in this cross-sectional study. The letter contained 
a cover letter with a request to answer the Quality of Life after 
Brain Injury (QOLIBRI) questionnaire as well as an addressed 
and prepaid envelope. Direct telephone calls or a second con-
tact reminder telephone call were not allowed after discharg-
ing due to the Schoen Clinic’s data protection norms. In cases 
with severe cognitive and/or motor impairment, the patient’s 
caregiver helped in completing the questionnaire. One major 
advantage of the QOLIBRI instrument is that self-completion 
is not a requirement and 28% of our chronic TBI patients 
were supported by their caregivers to complete the QOLIBRI. 
Patients were considered as having received decompressive cra-
niectomy (DC+) if bone flap reimplantation was documented 
and not directly performed after the primary neurosurgery. 
Reasons for DC are described according to all available neu-
rosurgical information in the referral letter and the medical 
records. All investigated TBI patients received critical care in 
a hospital of the Southern Upper-Bavaria Trauma Network, 
thereby assuring a comparable and high standard of critical 
and surgical care (17). According to local legislation (Bayer-
isches Krankenhausgesetz) and the ethical committee of the 
Ludwig-Maximilians University, Munich, Germany, ethics ap-
proval was not required for this study.
Demographic Data
To rule out nonresponder bias, demographic data and baseline 
characteristics were evaluated for the main unit (n = 439), the 
nonresponder (n = 251) and the QOLIBRI cohort (n = 135) 
including as follows: 1) TBI severity, 2) TBI etiology, 3) age 
at TBI, 4) age at survey, 5) elapsed time since TBI, 6) sex dis-
tribution, 7) whether a DC was performed, 8) whether an in-
tracranial pressure probe or a permanent shunt device was 
implanted, 9) whether a tracheostomy was performed, 10) 
time to onset of neurorehabilitation, 11) duration of neuro-
rehabilitation, and 12) functional status at admission, and 13) 
at discharge from neurorehabilitation (Table S1, Supplemental 
Digital Content 1, http://links.lww.com/CCM/F490). The rel-
ative frequency (%) of each TBI severity level was quantified 
using the established categories: mild (Glasgow Coma Scale 
[GCS] 13–15), moderate (GCS 9–12), or severe (GCS 3–8), 
based on the initially documented score on the GCS (18).
QOLIBRI: A Disease-Specific Instrument
The QOLIBRI is validated to assess HRQoL in patients after 
brain injury (19, 20), with a QOLIBRI total score from zero to 
100, representing lowest and highest HRQoL, respectively. A 
QOLIBRI total score of 60 or higher represents good HRQoL; 
a score below 60 indicates an increased risk for one psychi-
atric disorder, either affective or anxiety disorder, and a score 
below 40 for dual psychiatric disorders (20). The QOLIBRI 
instrument consists of the following six scales with a total of 
37 items: cognition (seven items), self (seven items), daily life 
and autonomy (seven items), social relationships (six items), 
emotions (five items), and physical problems (five items). Two 
major key aspects in the life scale, satisfaction and restrictions, 
are assessed by merging items one through four (cognition, 
self, daily life and autonomy, social relationships) and items 
five and six (emotions and physical problems), with maximum 
scores of 400 and 200, respectively.
DC and HRQoL
In the QOLIBRI cohort (n = 135), absolute frequencies of no 
decompressive craniectomy (DC–) and DC+ were quantified 
for each TBI severity group. The HRQoL, measured by the 
QOLIBRI total score, two key aspects, and six subscales, were 
compared between noncraniectomized (n = 98) and craniec-
tomized (n = 37) TBI patients. Furthermore, group differences 
between DC– and DC+ patients and their HRQoL were ana-
lyzed for the initial classified TBI severity, the age at TBI, the 
age at survey, and the elapsed time since TBI.
Data Management
All QOLIBRI questionnaires were checked for completeness, 
and self- or caregiver-assessed rating. Each QOLIBRI re-
sponder was then assigned an interim identification number. 
The QOLIBRI scores were added to the demographic and basic 
characteristics obtained from the medical records. Then the 
entire data set was anonymized.
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Statistical Analysis
Descriptive statistics was used to investigate group differences be-
tween DC– (n = 98) and DC+ (n = 37) patients analyzing HRQoL 
measured by the QOLIBRI total score, the two key aspects and the 
six subscales using the Mann-Whitney U test for numerical data. 
Distribution of HRQoL measured by the QOLIBRI total score 
is given as relative frequencies (%) for DC– and DC+ patients. 
QOLIBRI total scores greater than or equal to 60 were descriptively 
compared between DC– and DC+ patients using the Fisher exact 
test for categorical analysis. HRQoL (QOLIBRI total score) was 
compared between DC– and DC+ patients for each initial classi-
fied TBI severity group, that is, mild (n = 18), moderate (n = 18), 
or severe (n = 48) TBI using the Mann-Whitney U test. To assess 
nonresponder bias, group differences were calculated between the 
QOLIBRI cohort (n = 135) and the nonresponder group (n = 251) 
using the Fisher exact test for categorical and the Mann-Whitney 
U test for numerical variables. Statistical analysis was performed 
using R (R Core Team, Vienna, Austria). Data are reported as me-
dian with interquartile range (25–75%) (QOLIBRI results), ab-
solute frequency, relative frequency (%), the mean ± sem, or the 
mean ± sd. Differences were considered significant at p value of 
less than 0.05. Four of the 139 returned questionnaires were in-
complete and therefore excluded.
RESULTS
QOLIBRI Cohort and DC
One-hundred thirty-five out of 439 TBI patients completed 
the analysis, from now on termed as the “QOLIBRI cohort.” 
Thirty-seven (27%) out of 135 TBI patients underwent DC dur-
ing primary care and were representative in most parameters 
for 133 DC+ patients of the entire cohort (Fig. 1; and Table S1, 
Supplemental Digital Content 1, http://links.lww.com/CCM/
F490). Patients of the QOLIBRI cohort (n = 135) were slightly 
younger when experiencing TBI (p = 0.08), needed shorter neu-
rorehabilitation (p = 0.08) and gained better functional status at 
discharge from neurorehabilitation with a mean (± sem) modi-
fied Rankin Scale (mRS) of 2.3 ± 0.1 in comparison to the non-
responders (n = 251) with a mean (± sem) mRS of 3.1 ± 0.1 (p 
< 0.001). Thus, the nonresponders remained moderate disabled 
though able to walk unassisted, while patients of the QOLIBRI 
cohort gained good mobility and independence in activities of 
daily living though unable to carry out all previous activities.
DC and HRQoL After TBI
Analyzing HRQoL in DC– and DC+ patients revealed no sta-
tistical group difference. Noncraniectomized and craniecto-
mized patients reported a median QOLIBRI total score of 67 
and 75, respectively (Fig. 2A). Thus, 8% more craniectomized 
TBI patients reported good HRQoL with a QOLIBRI total score 
greater than or equal to 60 in comparison to DC– patients, 
namely 62% of DC– and 70% of DC+ patients (p = 0.004) 
(Fig. 2, B and C). In detail, 23% DC– versus 14% DC+ were at 
risk for one and 15% DC– versus 16% DC+ for two psychiatric 
disorders, respectively (Fig. 2C).
DC and Physical Status
HRQoL regarding physical status was slightly better in DC+ 
compared with DC– patients (p = 0.025) (Fig. 3). HRQoL with 
respect to the two key aspects, 
satisfaction and restriction, as 
well as the other five out of six 
subscales did not show signif-
icant group differences (Fig. 
S1, Supplemental Digital Con-
tent 2, http://links.lww.com/
CCM/F542; and Table S2, 
Supplemental Digital Content 
1, http://links.lww.com/CCM/
F490).
DC and Initial TBI 
Severity
DC was necessary in all initial 
TBI severity groups classified 
by the initial GCS. Six out of 
18 (33%) initially mild, seven 
out of 18 (39%) moderate, and 
10 out of 48 (21%) severe clas-
sified TBI patients underwent 
DC during the acute treatment 
(Fig. 4). Initially mild classi-
fied TBI patients had a me-
dian QOLIBRI total score of 
83 (DC+) compared with 62 
Figure 1. Flowchart depicting chronic traumatic brain injury (TBI) patients. In this cross-sectional study, 135 
chronic TBI patients without (n = 98) or with (n = 37) decompressive craniectomy reported their health-related 
quality of life up to 10 yr after neurorehabilitation. One-hundred thirty-five out of the 150 survey participants 
represent a net response rate of 90% as previously described. QOLIBRI = Quality of Life after Brain Injury.
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(DC–) (p = 0.028) (Fig. 4). None of the DC+ and initially mild 
injured scored below 60, representing good HRQoL. This effect 
was less noticeable and not significant in moderately and not 
given in severely brain injured patients. Fourteen out of 51 TBI 
patients (28%) received DC and were not classified for their 
initial TBI severity (Fig. S2, Supplemental Digital Content 2, 
http://links.lww.com/CCM/F542).
Reasons for DC in the initially mild TBI patients were 
both, that is, evacuation of mass lesion and intracra-
nial hypertension, according to available data (Table S5, 
Supplemental Digital Content 1, http://links.lww.com/CCM/
F490). Most DC+ patients were initially referred to the ICU 
of Schoen Rehabilitation Center and suffered from mod-
erate to severe disability according to the mRS at admission 
to neurorehabilitation. In de-
tail, DC+ patients who were 
initially classified mild had a 
mean (± sd) mRS of 4.7 ± 0.5 
at admission to neurorehabil-
itation and the bone flap was 
replaced 3 ± 1.5 months after 
TBI (mean ± sd), indicating 
a secondary deterioration 
after the brain impact (Tables 
S4 and S5, Supplemental 
Digital Content 1, http://
links.lww.com/CCM/F490). 
DC– and DC+ groups did 
not differ in function at ad-
mission to neurorehabilita-
tion but DC+ patients who 
were initially classified mild 
or moderate regained bet-
ter function, while initially 
severe or not classified DC+ 
patients suffered from severe 
disability at discharge from 
neurorehabilitation (Table S4, 
Supplemental Digital Content 
1, http://links.lww.com/
CCM/F490). DC+ patients of 
the initial mild to moderate 
TBI severity groups were able 
to walk unassisted or became 
even independent in daily ac-
tivities though results were 
not significant in comparison 
to the DC– patients.
DC and Age-Related 
Aspects for HRQoL
DC showed a trend to-
ward better HRQoL in the 
61–85-year-old (age at TBI) reflected by a median QOLIBRI 
total score of 62 (DC–) versus 79 (DC+) (p = 0.06) (Fig. 5). 
HRQoL in terms of age at survey indicate more DC+ patients 
with good outcome compared with the DC– patients albeit not 
significant (Fig. S3, Supplemental Digital Content 2, http://
links.lww.com/CCM/F542).
DC and Elapsed Time Since TBI
TBI patients, who underwent DC in the acute phase, showed 
a trend toward better HRQoL over time since the brain in-
jury (Fig. S4, Supplemental Digital Content 2, http://links.
lww.com/CCM/F542). During the first year after TBI, HRQoL 
was impaired in the noncraniectomized group with a median 
QOLIBRI total score of 50, while the small group of three 
C
A B
Figure 2. Decompressive craniectomy and health-related quality of life (HRQoL) following traumatic brain  
injury. The Quality of Life after Brain Injury (QOLIBRI) total score equal or above 60 indicates good HRQoL  
comparable to the healthy general population (gray line). A score below 60 (hatched) indicates a risk for one  
and a score below 40 (closely hatched) for both psychiatric disorders, namely anxiety or/and depressive  
disorder. A, Descriptive comparison of no decompressive craniectomy (DC–) (white bar) and decompressive  
craniectomy (DC+) (gray bar) patients revealed no statistical group difference using the Mann-Whitney U test.  
B, Of DC– patients, 62% (top, white bars). C), Of DC+ patients, 70%  (bottom, gray bars) reported good HRQoL  
with a QOLIBRI total score equal or above 60 (p = 0.004). Thus, 8% of patients who underwent DC were more 
satisfied according to their self-assessed HRQoL. The risk for one (hatched) or even two (closely hatched) 
psychiatric disorders differed between DC– and DC+ groups: 23% (DC–) versus 14% (DC+) and 15% (DC–) 
versus 16% (DC+), respectively. DC– = no decompressive craniectomy, DC+ = decompressive craniectomy.
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craniectomized TBI patients displayed a much higher, al-
though not statistically significant, score of 97 (p = 0.09).
DISCUSSION
In this cross-sectional study, 135 craniectomized or noncra-
niectomized TBI patients reported on their HRQoL up to 10 
years after neurorehabilitation. DC was indicated in all initially 
classified TBI severity groups and most beneficial in the ini-
tially mildly injured suggesting a possibly advantageous effect 
of DC for patients prone to secondary deterioration follow-
ing TBI. A larger portion of patients with DC reported good 
HRQoL and were more content with their physical status. DC 
might result in better HRQoL outcome in the elderly, namely 
61–85-year-old patients, pointing out the value of providing 
the highest medical care in the elderly population.
Cross-Sectional Study Design and Chronic TBI 
Cohort
Most demographic data and basic characteristics did not differ 
between the QOLIBRI cohort and the nonresponders. How-
ever, patients of the QOLIBRI cohort were slightly younger 
when experiencing TBI, needed shorter neurorehabilitation 
and gained better functional status at discharge from neuro-
rehabilitation with a mean mRS of 2, indicating slight disa-
bility with good mobility and independence in activities of 
daily living though unable to carry out all previous activities, 
while the nonresponders remained moderate disabled. Thus, a 
nonresponder bias cannot fully be excluded. This chronic TBI 
cohort experienced TBI between 2005 and 2015 and under-
went neurorehabilitation at the Schoen Clinic, Bad Aibling, 
Germany, one of the largest neurorehabilitation centers in Eu-
rope. All patients were directly referred to neurorehabilitation 
by certified TBI centers, thereby receiving the highest possible 
standard of surgical and medical primary care. As time to onset 
of neurorehabilitation and neurorehabilitation procedures 
themselves are relevant outcome factors (21), the one center 
design of our study secured a high level of therapeutic homo-
geneity within our patient cohort.
DC and Good HRQOL
One third of patients underwent DC and 70% of these patients 
reported good HRQoL as compared to only 62% in the non-
craniectomized group up to 10 years after TBI. So far, only two 
long-term outcome studies have reported HRQoL in patients 
having received DC with a median follow-up of 12 months 
using the QOLIBRI and of 49 months using the 36-item 
Short Form survey instrument. Both studies did not compare 
HRQoL to noncraniectomized patients and included only rela-
tively young patients with a mean age between 27 and 33 years 
(22, 23). Thus, this is the first controlled study investigating 
long-term HRQoL in TBI patients with or without DC.
The validity and quality of the current analysis might be 
further estimated by comparing our results to the already pub-
lished QOLIBRI validation cohort (23). The 795 TBI patients 
in that cohort had a mean (± sd) QOLIBRI total score of 
64.6 ± 18.2, a value very well in line to the 64.3 ± 22.4 obtained 
in our 94 noncraniectomized control patients (Table S3, 
Supplemental Digital Content 1, http://links.lww.com/CCM/
F490). Hence, in comparison with a much larger TBI cohort, 
our HRQoL results are robust and comparable. Given the 
fact that there is no QOLIBRI validation cohort reporting on 
HRQoL following DC this current analysis might be a first step 
for a validation cohort after DC in TBI patients.
Risk for Post-Traumatic Psychiatric Sequels
Thirty-eight percent of noncraniectomized and 30% of DC+ 
patients were at risk for psychiatric disorders following TBI, 
that is, DC was associated with a reduced risk for post-trau-
matic psychiatric disorders. This increased risk was highest in 
those noncraniectomized patients initially classified as mild as 
well as during the first year after experiencing the TBI. Most 
probably this increased risk, namely for anxiety and/or depres-
sive disorders, did not preexist before injury, but was induced 
by TBI itself as the presented results are comparable to the 
QOLIBRI validation cohort, which excluded patients with pre-
existing psychiatric disorders (24).
DC and Physical Status
Patients who received DC during the acute phase were more 
satisfied with their physical status compared with DC– 
patients. As aforementioned, RESCUEicp failed to clearly 
show a better physical outcome at 6 months with a tendency 
for physical improvement at 12 months after TBI (12), while 
in the DECRA trial physical outcome was worse at 6 months 
Figure 3. Decompressive craniectomy and physical status. Health-
related quality of life regarding physical status was slightly better in 
DC+ compared with DC– patients using the Mann-Whitney U test for 
descriptive group comparison (p = 0.025). DC– = no decompressive 
craniectomy, DC+ = decompressive craniectomy.
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after DC following TBI (13). Another study reported on bet-
ter functional recovery (GOSE) up to 18 months following 
DC after TBI in those patients with higher initial GCS (25). 
Thus, we suggest that objective physical disability is only one 
component of the overall long-term outcome after TBI and 
probably not the most important one in the long run. There-
fore, our result underline the need for multilevel long-term 
outcome assessments including subjective such as HRQoL and 
objective measures such as the 
GOSE after TBI as previously 
suggested by Maas et al (2). 
Furthermore, the observation 
period post-TBI is particu-
larly relevant and future stud-
ies evaluating the therapeutic 
efficacy of interventions and 
drugs will need to take this cir-
cumstance into account when 
investigating TBI outcome.
DC in Initially Mild or 
Moderate Classified TBI
In our cohort of chronic TBI 
patients, 27% were initially 
classified with mild and mod-
erate TBIs. The fact that these 
patients finally needed neuro-
rehabilitation and had com-
parable clinical characteristics 
as severe TBI patients (Table 
S4, Supplemental Digital Con-
tent 1, http://links.lww.com/
CCM/F490), strongly suggests 
that these patients secondarily 
deteriorated. This secondary 
deterioration most probably 
explains why 33% of initially 
mild (GCS 13–15) and 39% of 
initially moderate (GCS 9–12) 
TBI patients received the indi-
cation for DC. This finding of 
secondary deterioration and 
the necessity of neurorehabili-
tation after TBI is well in line 
with a recent meta-analysis 
(26). Other studies even sug-
gest that 64% to 75% of the 
patients initially classified with 
mild TBI may have an unfa-
vorable long-term outcome (8, 
27, 28). These findings under-
line the need for a better TBI 
classification beyond mild, 
moderate, or severe accord-
ing to the GCS—as aimed 
by the ongoing TBI studies 
Transforming Research and Clinical Knowledge in Traumatic 
Brain Injury (TRACK-TBI) and Collaborative European Neu-
roTrauma Effectiveness Research in Traumatic Brain Injury 
(CENTER-TBI). There is no doubt, that GCS is a most val-
uable parameter during the emergency, but less suitable for 
determining TBI prognosis and outcome. Regarding HRQoL, 
none of the initially mild classified decompressed TBI patients 
scored below 60. Thus, these patients have a very low risk to 
Figure 4. Decompressive craniectomy (DC) and initial traumatic brain injury (TBI) severity. DC was indicated 
in patients of all TBI severity groups representing the well-known occurrence of secondary deterioration. Six 
out of 18 initially classified as mild TBI patients suffered from moderate to severe disability when admitted to 
neurorehabilitation and benefitted the most from DC (p = 0.028). Mild, moderate, or severe TBI was defined 
according to the initial Glasgow Coma Scale of 13–15, 9–12, or 3–8, respectively. DC– = no decompressive 
craniectomy, DC+ = decompressive craniectomy, QOLIBRI = Quality of Life after Brain Injury.
Figure 5. Decompressive craniectomy (DC) and age-related health-related quality of life (HRQoL). Age at 
traumatic brain injury (TBI) is not a predictor for good outcome regarding HRQoL in our chronic TBI patients. 
DC was associated with a better HRQoL in the 61–85-yr-old reflected by a median Quality of Life after Brain 
Injury (QOLIBRI) total score of 62 (DC–) versus 79 (DC+) with p = 0.06 in the analysis for group differences. 
DC– = no decompressive craniectomy, DC+ = decompressive craniectomy.
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develop anxiety or depression and may therefore have a good 
long-term prognosis.
DC in the Elderly and Time Since TBI
DC was most favorable for the 61–85-year-olds with most 
patients reporting good HRQoL, pointing out the value of pro-
viding the highest medical care in the elderly population, even 
though DC is less economically attractive in the elderly and 
their physical outcome might be limited thereafter (29, 30). In-
terestingly, the Paris Severe Traumatic Brain Injury (PariSTBI) 
study analyzed HRQoL after severe TBI and showed that the 
QOLIBRI total score is associated with the patient´s disability 
level. In detail, a QOLIBRI total score of equal or above 64 
represents moderate recovery on the GOSE and a score equal 
or above 82 a good recovery on the GOSE (31). Thus, we can 
possibly assume moderate to good recovery in the elderly 
DC+ patients up to 10 years after the brain impact. During 
the first year after experiencing TBI, most DC– patients re-
ported impaired HRQoL, while the majority of DC+ patients 
were satisfied indicating a better adaption or resilience to the 
post-traumatic condition in the craniectomized patients. But 
this latter interpretation needs to be handled with care due 
to the small sample size and because a selection bias during 
the decision process for DC cannot be excluded. If so, it is im-
portant to elucidate the patterns of decision-making for DC 
following TBI in the future, which will be easier due to the 
recently published consensus on the “Role of Decompressive 
Craniectomy in the Management of Traumatic Brain Injury” 
(32). However, previous data show that time since TBI is not a 
predictor for good HRQoL outcome and the majority of TBI 
patients already report satisfactory HRQoL 1 year after TBI.
Regarding generalizability, this is the first explorative ev-
idence, that DC is associated with improved HRQoL up to 
10 years after TBI. The only other study using the QOLIBRI 
questionnaire and investigating this topic, had significantly 
lower HRQoL values in decompressed TBI patients (60 ± 21 
vs 68.8 ± 23 in our cohort), but included only young adults 
treated in a tertiary care urban center with a median follow-up 
of 12 months (range, 6–18 mo) and a control group was miss-
ing (22). Hence, the patients´ age and time of follow-up may 
explain the differences between the two studies, since our study 
showed that increased age and length of follow-up influenced 
HRQoL outcome.
Nevertheless, there are several limitations with this study 
that warrant discussion. First, we cannot fully exclude a non-
responder bias as the QOLIBRI cohort had better function at 
discharge from neurorehabilitation compared with the non-
responders. Second, there is a lack of detailed neurosurgical 
information of the treatment of DC– and DC+ patients and 
reasons for DC remain vague, that is: 1) either primary DC 
due to an acute bleeding or secondary neuroprotective or life-
saving, 2) the time period, management and the maximum 
of intracranial hypertension, 3) the exact time between brain 
injury and DC, and 4) the size of DC, and thus precise inter-
pretation of the beneficial effects of DC is limited. Third, the 
postsurgical hemispheric diameter, a potential predictor for 
good functional outcome following DC, was not obtainable 
(33). Fourth, information on pharmacotherapy to tackle in-
tracranial hypertension was very limited for both DC– and 
DC+ groups in medical reports sent to the neurorehabilitation 
center and certainly needs attention in future studies. Fifth, 
neuroimaging data using diffusion tensor imaging to precisely 
stratify for TBI injury patterns was not available as it was (and 
is still) not “state of the art” during the 2005 to 2015 study pe-
riod. Sixth, TBI severity classification was limited due to miss-
ing GCS documentation in 38% of patients—factors being 
well in-line with previous studies, and thus represent a com-
mon problem for TBI treatment and outcome research (26, 
27, 34). Seventh, this cross-sectional study does not provide 
a multilevel assessment including object measures on func-
tional outcome, for example, the GOSE, or cognition. These 
assessments are in principle easy to get via phone but phon-
ing former patients is not allowed due to the Schoen Clinic’s 
data protection norms. However, results from the PariS-TBI 
study suggest that a QOLIBRI total score of equal or above 64 
represents moderate recovery on the GOSE and a score equal 
or above 82 a good recovery on the GOSE (31). Thus, we can 
possibly assume moderate to good recovery in our chronic 
TBI cohort. Nevertheless, future and confirmatory prospective 
studies need to assess subjective and objective measures in-
cluding HRQoL, functional and cognitive long-term outcome.
CONCLUSIONS
Our results suggest that DC is associated with good HRQoL up 
to 10 years after TBI. DC was indicated in all initially classified 
TBI severity groups with a significant better HRQoL after DC 
in the initially mildly injured who most probably have deterio-
rated, as indicated by the moderate to severe disability when 
admitted to neurorehabilitation. The elderly, 61–85-year-old 
TBI patients, showed a tendency for better HRQoL after DC. 
Thus, we emphasize the need for multidimensional outcome 
assessments to better understand the long-term outcome of 
TBI patients having or having not received DC during acute 
treatment.
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